Takeda Announces Candidates for New Directors

May 14, 2019

Osaka, Japan, May 14, 2019, --- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has decided the candidates for new Directors which will be proposed to the 143rd Ordinary General Meeting of Shareholders on June, 2019. The candidates are as follows;

1.Candidates for Non-Audit and Supervisory Committee Directors

Name

Category

Current Role

Christophe Weber

Internal

Existing

Representative Director,
President & Chief Executive Officer

Masato Iwasaki

Internal

Existing

Director, President, Japan Pharma Business Unit

Andrew Plump

Internal

Existing

Director, President, Research & Development

Constantine Saroukos

Internal

New

Corporate Officer, Chief Financial Officer

Masahiro Sakane

External

Existing

External Director, Chair of the Board Meeting

Olivier Bohuon

External

Existing

External Director

Ian Clark

External

Existing

External Director

Yoshiaki Fujimori

External

Existing

External Director

Steven Gillis

External

Existing

External Director

Toshiyuki Shiga

External

Existing

External Director

Jean-Luc Butel

External

New

External Director, Audit & Supervisory Committee member

Shiro Kuniya

External

New

External Director, Head of Audit & Supervisory Committee

Among the above candidates, Jean-Luc Butel and Shiro Kuniya will resign as Audit & Supervisory Committee Directors at the close of the 143rd Ordinary General Meeting of Shareholders.

2.Candidates for Audit and Supervisory Committee Directors

Name

Category

Current Role

Emiko Higashi

External

New

External Director

Michel Orsinger

External

New

External Director

Audit & Supervisory Committee Directors (Yasuhiko Yamanaka and Koji Hatsukawa) are within their 2-year tenure, and are not subjects for reelection this year.


Media Contact:
Kazumi Kobayashi
kazumi.kobayashi@takeda.com
+81 (0) 3-3278-2095